Skip to main content

Series B Biotechnology Companies

Explore 430 biotechnology startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
430
Total Funding
$1.4B
Avg Funding
$55.4M
Cities
22

Export 430 Series B Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Schlieren, Switzerland
$130.0M
raised

GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.

May 2025
Series B

Founder Contacts

41,000+ verified contacts

Eindhoven, The Netherlands
$60.4M
raised

Salvia BioElectronics develops neuromodulation devices for migraine treatment and management.

May 2025
Series B

Founder Contacts

41,000+ verified contacts

Oakdale, United States
$52.0M
raised

Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.

May 2025
Series B

Founder Contacts

41,000+ verified contacts

Helsinki, Finland
$25.3M
raised

TILT Biotherapeutics Ltd is the leading company globally working in the area of enabling tumor.

May 2025
Series B

Founder Contacts

41,000+ verified contacts

Leiden, The Netherlands
$146.7M
raised

Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.

May 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States
$50.0M
raised

Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.

May 2025
Series B

Founder Contacts

41,000+ verified contacts

Singapore, Singapore
$45.0M
raised

Nuevocor operates as a preclinical-stage biotech company.

May 2025
Series B

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$5.0M
raised

Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.

May 2025
Series B

Founder Contacts

41,000+ verified contacts

Golden, United States
$10.0M
raised

Transverse Medical is a medical equipment manufacturing company.

Apr 2025
Series B

Founder Contacts

41,000+ verified contacts

Basel, Switzerland
$70.0M
raised

Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.

Apr 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Newark, United States
$29.4M
raised

Ace Vision Group develop laser-based therapeutic technologies to heal age-related eye dysfunction and restore the eye's natural performance.

Apr 2025
Series B

Founder Contacts

41,000+ verified contacts

Lehi, United States
$6.0M
raised

PhotoPharmics is a medical device company that develops treatments for treating neurodegenerative disorders.

Apr 2025
Series B

Founder Contacts

41,000+ verified contacts

Dublin, Ireland
$76.0M
raised

Juvenescence is a biotech company that develops therapies and products to modify aging and help people live longer.

Apr 2025
Series B

Founder Contacts

41,000+ verified contacts

Nishiku, Japan
$3.8M
raised

KAICO is a biotechnology company that provides hard-expressing proteins to develop drugs with a silkworm-baculovirus expression system.

Apr 2025
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$59.2M
raised

Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.

Apr 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Aachen, Germany
$25.2M
raised

Medical AI company with a focus on critical care.

Apr 2025
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$155.0M
raised

AIRNA develops RNA editing technologies to create medicines for various diseases.

Apr 2025
Series B

Founder Contacts

41,000+ verified contacts

Torun, Poland
$2.9M
raised

Fresh Inset Vision is to save the fresh produce resources by delivering efficient and seamless Vidre+ technology.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

Oakland, United States
$70.0M
raised

Tempero Bio develops treatments for Substance Use Disorders as a clinical-stage biopharmaceutical company.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$65.0M
raised

Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Thousand Oaks, United States
$150.0M
raised

Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

Bothell, United States
$110.0M
raised

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$18.0M
raised

Gallant is advancing investigational stem cell therapies to help give pets more good years, making regenerative care more accessible.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

Dublin, Ireland
$10.9M
raised

Neuromod Devices has developed LENIRE® (www.lenire.com) a non-invasive bimodal neuromodulation therapy for tinnitus.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

Lyon, France
$10.5M
raised

Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

Showing 126 to 150 of 430 companies

Ready to Connect with Series B Biotechnology Startups?

Get verified founder emails, funding details, and company data for 430 series b biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

430 Biotechnology Series B Startups (November 2026) — Page 6 | VCBacked